Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses

Objectives:HIV-infected subjects are at increased risk for myocardial infarction. The mechanism of this increased risk remains unclear. Since cytomegalovirus (CMV) infection has been associated with accelerated atherosclerosis in the transplant population and immune responses against CMV may be altered by HIV disease, we hypothesized that enhanced T-cell responses against CMV would be associated with increased atherosclerosis in subjects with HIV. Methods:We measured high-sensitivity C-reactive protein (hs-CRP), T-cell activation, CMV-specific T-cell responses, and carotid artery intima-media thickness (IMT) in 93 HIV-infected subjects and in 37 uninfected controls. Results:The mean age of the HIV-infected subjects was 48 years and 85 (91%) were male. The median carotid IMT was higher in the HIV-infected group compared to the uninfected group (0.95 mm versus 0.68 mm, P < 0.001). This difference remained significant after controlling for all traditional risk factors. Compared to HIV-negative controls, HIV-infected subjects had higher median levels of hs-CRP (P = 0.05), higher levels of CD4 and CD8 T-cell activation (P < 0.0001) and higher CMV-specific interferon-γ CD8 T-cell responses (P < 0.0001). CMV-specific T-cell responses, but not hs-CRP and T-cell activation, were independently associated with higher carotid IMT (P = 0.001). Conclusions:HIV-infected subjects had thicker carotid IMT compared to controls. While HIV patients also had higher T-cell activation, hs-CRP levels, and CMV-specific T-cell responses, only CMV-specific T-cell responses were independently associated with IMT. Accelerated atherosclerosis in HIV patients may be mediated by heightened CMV-induced immune responses.

[1]  W. K. Henry,et al.  Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure , 2005, AIDS.

[2]  R. Kronmal,et al.  Azithromycin for the secondary prevention of coronary events. , 2005, The New England journal of medicine.

[3]  Charles E. McCulloch,et al.  Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .

[4]  V. Maino,et al.  Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.

[5]  B. Coll,et al.  Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele , 2004, Circulation.

[6]  S. Josefowicz,et al.  CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals. , 2004, Viral immunology.

[7]  Peter Hunt,et al.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.

[8]  Jeffrey N. Martin,et al.  Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection , 2004, Circulation.

[9]  Tao Dong,et al.  Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection , 2004, PLoS biology.

[10]  D. Waters,et al.  Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection , 2004, Circulation.

[11]  Jeffrey N. Martin,et al.  Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. , 2004, The Journal of infectious diseases.

[12]  D. Costagliola,et al.  Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men , 2003, AIDS.

[13]  Todd M. Allen,et al.  Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences , 2003, Journal of Virology.

[14]  A. Simon,et al.  Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients. , 2003, Journal of acquired immune deficiency syndromes.

[15]  S. Kaul,et al.  Acute myocardial infarction in human immunodeficiency virus-infected patients. , 2003, Archives of internal medicine.

[16]  S. Rowland-Jones,et al.  Premature ageing of the immune system: the cause of AIDS? , 2002, Trends in immunology.

[17]  John M Williamson,et al.  Protease inhibitors and cardiovascular outcomes in patients with HIV-1 , 2002, The Lancet.

[18]  A. Telenti,et al.  Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. , 2002, Blood.

[19]  S. Sidney,et al.  Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV‐1 Infection? , 2002, Journal of acquired immune deficiency syndromes.

[20]  J. Kahn,et al.  Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. , 2002, Journal of acquired immune deficiency syndromes.

[21]  C. Tinelli,et al.  Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. , 2002, Atherosclerosis.

[22]  S. Hunt,et al.  IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone , 2001, Transplantation.

[23]  J. McCune,et al.  The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.

[24]  A. Telenti,et al.  Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy , 2001, AIDS.

[25]  D. Nixon,et al.  Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. , 2001, Virology.

[26]  G. Serio,et al.  Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors , 2000, AIDS.

[27]  B. Horne,et al.  Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease , 2000, Circulation.

[28]  H. Schuitemaker,et al.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock , 2000, Nature Immunology.

[29]  R. Loire,et al.  Accelerated coronary atherosclerosis and arteriosclerosis in young human‐immunodeficiency‐virus‐positive patients , 2000, Coronary artery disease.

[30]  T. Merigan,et al.  Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. , 1999, Circulation.

[31]  J V Giorgi,et al.  Quantitation of CD38 expression using QuantiBRITE beads. , 1998, Cytometry.

[32]  R. Detels,et al.  CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[33]  D. Ho,et al.  HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy , 1998, The Journal of experimental medicine.

[34]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[35]  C. Pitcher,et al.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.

[36]  M. Leon,et al.  Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. , 1996, The New England journal of medicine.

[37]  D. Weissman,et al.  The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation , 1996, The Journal of experimental medicine.

[38]  M. Daemen,et al.  Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. , 1995, Circulation.

[39]  A. Folsom,et al.  Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study. , 1992, Annals of epidemiology.

[40]  L. Chambless,et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.

[41]  R. Detels,et al.  T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.

[42]  V. Starnes,et al.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.

[43]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[44]  Rodolphe Thiébaut,et al.  Combination antiretroviral therapy and the risk of myocardial infarction , 2003 .

[45]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[46]  W. Roos,et al.  Development of a new microparticle‐enhanced turbidimetric assay for C‐reactive protein with superior features in analytical sensitivity and dynamic range , 1998, Journal of clinical laboratory analysis.

[47]  S. Chou,et al.  Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[48]  M. V. van Dam-Mieras,et al.  The possible role of cytomegalovirus in atherogenesis. , 1991, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.